ArticlemedRxiv : the preprint server for health sciences2026
Personal Care Products and Incident Hypertension: Prospective Cohort Study of U.S. Women.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Over half of U.S. women have hypertension, a strong but modifiable risk factor for cardiovascular diseases. Personal care products (PCPs) are widely used in daily life and contain endocrine disrupting chemicals that can alter hormonal regulation of blood pressure. However, the relationship between PCPs and hypertension has not been well studied. We investigated whether patterns of PCP use were associated with incident hypertension in a large prospective cohort study of U.S. women. Methods: Sister Study participants were recruited in 2003-2009 and followed until September 30, 2021. Usage frequency of 41 PCPs in the 12 months before baseline was self-reported. Latent class analyses identified groups with similar PCP use patterns ("infrequent," "moderate," or "frequent"). At baseline, we excluded women with prevalent hypertension, antihypertensive medication users, or those missing hypertension status. Multivariable Cox regression was used to estimate associations between PCP use and incident self-reported hypertension. Results: During a mean follow-up of 11.4 years, 10,099 women developed hypertension. Frequent PCP use was associated with higher hypertension risk [HR=1.08 (95% CI: 1.03, 1.13); p-trend=0.003], with a 4.1% population attributable risk. Frequent users of beauty products had higher risk than infrequent users [HR=1.11 (95% CI: 1.05, 1.16)]. Moderate and frequent users of hygiene products also had increased risk [HR=1.07 (95% CI: 1.01, 1.13); HR=1.13 (95% CI: 1.08, 1.19)]. Conclusions: Frequent PCP use, especially beauty and hygiene products, was associated with incident hypertension. Our findings implicate everyday chemicals as modifiable cardiovascular risk factors and highlight the need to identify pathogenic components in widely used consumer products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.